Press Releases

Cerebrotendinous Xanthomatosis Market is Forecasted to Hit US$ 350.7 Mn By 2031 | CAGR 11.2%

The Global Cerebrotendinous Xanthomatosis Market is expected to reach US$ 350.7 Million by 2031, exhibiting a robust growth rate of 11.2% during the f

  • Date: 07 May, 2024
  • Author: Sagar Karlekar
Autism Spectrum Disorder Market is Forecasted to Hit US$ 15.7 Bn By 2031 | CAGR 12.3%

The Global Autism Spectrum Disorder (ASD) Market is projected to reach US$ 15.7 Bn by 2031, exhibiting a robust compound annual growth rate (CAGR) of

  • Date: 07 May, 2024
  • Author: Sagar Karlekar
Argininosuccinic Aciduria Market is Forecasted to Hit US$ 266.7 Mn By 2031 | CAGR 10.5%

The Argininosuccinic Aciduria Market is a niche segment within the pharmaceuticals industry, focused on developing and providing treatments for a rare

  • Date: 06 May, 2024
  • Author: Sagar Karlekar
Huntington's Disease Treatment Market is Forecasted to Hit US$ 4.4 Bn By 2031 | CAGR 17.8%

The Huntington's Disease Treatment Market is projected to grow at a CAGR of 17.8% from 2024 to 2031 and reach a market size of US$ 4.4 billion by

  • Date: 04 May, 2024
  • Author: Sagar Karlekar
Stem Cell Therapy Market is Forecasted to Hit US$ 24.1 Bn By 2031 | CAGR 12.8%

The Global Stem Cell Therapy Market is expected to reach US$ 24.1 Bn in 2031, with a growth rate of 12.8% during the forecast period of 2024-2031. Ste

  • Date: 29 Apr, 2024
  • Author: Sagar Karlekar
CRISPR Gene Editing Market is Forecasted to Hit US$ 11.1 Bn By 2031 | CAGR 32.1%

The CRISPR Gene Editing Market is a part of the biotechnology industry, which falls under the broader healthcare sector. This revolutionary technology

  • Date: 29 Apr, 2024
  • Author: Sagar Karlekar
Global Insomnia Market is Forecasted to Hit US$ 7.5 Bn By 2031 | CAGR 11.2%

The Global Insomnia Market, encompassing both pharmaceutical and non-pharmaceutical solutions for the treatment of insomnia, is projected to reach a v

  • Date: 27 Apr, 2024
  • Author: Sagar Karlekar
Inherited Retinal Disease Market is Forecasted to Hit US$ 8.0 Bn By 2031 | CAGR 18.2%

The Inherited Retinal Disease Market is a rapidly growing segment within the pharmaceutical and biotechnology industry, focused on developing treatmen

  • Date: 27 Apr, 2024
  • Author: Sagar Karlekar
Angio Suites Market is Forecasted to Hit US$ 3.2 Bn By 2031 | CAGR 7.5%

The Global Angio Suites Market, which falls under the medical devices industry, is witnessing remarkable growth driven by the increasing prevalence of

  • Date: 25 Apr, 2024
  • Author: Sagar Karlekar
Anti-retropulsion Devices Market is Forecasted to Hit US$ 3.4 Bn By 2031 | CAGR 8.1%

The Global Anti-retropulsion Devices Market is expected to reach US$ 3.4 Billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1% from

  • Date: 21 Apr, 2024
  • Author: Sagar Karlekar